-
1
-
-
0009547624
-
American Diabetes Association Consensus Statement. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes
-
American Diabetes Association
-
American Diabetes Association. American Diabetes Association Consensus Statement. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diabetes Care 12 (1989) 573-579
-
(1989)
Diabetes Care
, vol.12
, pp. 573-579
-
-
-
2
-
-
0032515775
-
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus. United Kingdom Prospective Diabetes Study (UKPDS: 23)
-
United Kingdom Prospective Diabetes Study Group
-
Turner R.C., Millns H., Neil H.A.W., Stratton I.M., Manley S.E., Matthews D.R., Holman R.R., and United Kingdom Prospective Diabetes Study Group. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus. United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 316 (1998) 823-828
-
(1998)
BMJ
, vol.316
, pp. 823-828
-
-
Turner, R.C.1
Millns, H.2
Neil, H.A.W.3
Stratton, I.M.4
Manley, S.E.5
Matthews, D.R.6
Holman, R.R.7
-
3
-
-
0021741512
-
Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease
-
Suarez L., and Barrett-Connor E. Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol 120 (1984) 670-675
-
(1984)
Am J Epidemiol
, vol.120
, pp. 670-675
-
-
Suarez, L.1
Barrett-Connor, E.2
-
5
-
-
0037354252
-
Cigarette smoking and diabetes
-
Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis 45 (2003) 405-413
-
(2003)
Prog Cardiovasc Dis
, vol.45
, pp. 405-413
-
-
Eliasson, B.1
-
7
-
-
0038240494
-
Relationship of walking to mortality among US adults with diabetes
-
Gregg E.W., Gerzoff R.B., Caspersen C.J., Williamson D.F., and Narayan K.M.V. Relationship of walking to mortality among US adults with diabetes. Arch Intern Med 163 (2003) 1440-1447
-
(2003)
Arch Intern Med
, vol.163
, pp. 1440-1447
-
-
Gregg, E.W.1
Gerzoff, R.B.2
Caspersen, C.J.3
Williamson, D.F.4
Narayan, K.M.V.5
-
8
-
-
84994371008
-
Obesity and diabetes
-
Bray G., and Bouchard C. (Eds), Marcel Dekker Inc, New York
-
Albu J., and Pi-Sunyer F.X. Obesity and diabetes. In: Bray G., and Bouchard C. (Eds). Handbook of Obesity (2004), Marcel Dekker Inc, New York 899-918
-
(2004)
Handbook of Obesity
, pp. 899-918
-
-
Albu, J.1
Pi-Sunyer, F.X.2
-
9
-
-
11844259382
-
Standards of medical care in diabetes 2005
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes 2005. Diabetes Care 28 suppl 1 (2005) S4-S36
-
(2005)
Diabetes Care
, vol.28
, Issue.SUPPL. 1
-
-
-
10
-
-
0035897696
-
Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2005) 2486-2497
-
(2005)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
11
-
-
0035500039
-
AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 Update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
-
Smith S.C., Blair S.N., Bonow R.O., Brass L.M., Cerqueira M.D., Dracup K., Fuster V., Gotto A., Grundy S.M., Miller N.H., et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 Update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 38 (2001) 1581-1583
-
(2001)
J Am Coll Cardiol
, vol.38
, pp. 1581-1583
-
-
Smith, S.C.1
Blair, S.N.2
Bonow, R.O.3
Brass, L.M.4
Cerqueira, M.D.5
Dracup, K.6
Fuster, V.7
Gotto, A.8
Grundy, S.M.9
Miller, N.H.10
-
12
-
-
0034688194
-
Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
-
Heart Outcomes Prevention Evaluation Study Investigators. [published corrections appear in N Engl J Med 2000;342:748 and 2000;342:1376]
-
Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G., and Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. [published corrections appear in N Engl J Med 2000;342:748 and 2000;342:1376]. N Engl J Med 342 (2000) 145-153
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
13
-
-
0037840242
-
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes. a randomized placebo-controlled trial
-
Heart Protection Study Collaborative Group
-
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes. a randomized placebo-controlled trial. Lancet 361 (2003) 2005-2017
-
(2003)
Lancet
, vol.361
, pp. 2005-2017
-
-
-
15
-
-
0027406191
-
Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
-
Stamler J., Vaccaro O., Neaton J., and Wentworth D. Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
-
(1993)
Diabetes Care
, vol.16
, pp. 434-444
-
-
Stamler, J.1
Vaccaro, O.2
Neaton, J.3
Wentworth, D.4
-
16
-
-
0025860342
-
A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women
-
Manson J.E., Colditz G.A., Stampfer M.J., Willett W.C., Królewski A.S., Rosner B., Arky R.A., Speizer F.E., and Hennekens C.H. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 151 (1991) 1141-1147
-
(1991)
Arch Intern Med
, vol.151
, pp. 1141-1147
-
-
Manson, J.E.1
Colditz, G.A.2
Stampfer, M.J.3
Willett, W.C.4
Królewski, A.S.5
Rosner, B.6
Arky, R.A.7
Speizer, F.E.8
Hennekens, C.H.9
-
17
-
-
0032554676
-
Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
-
West Scotland Coronary Prevention Group
-
West Scotland Coronary Prevention Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 97 (1998) 1440-1445
-
(1998)
Circulation
, vol.97
, pp. 1440-1445
-
-
-
18
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. results of AFCAPS/TexCAPS
-
Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., and Gotto Jr. A.M. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. results of AFCAPS/TexCAPS. JAMA 279 (1998) 1615-1622
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
Whitney, E.4
Shapiro, D.R.5
Beere, P.A.6
Langendorfer, A.7
Stein, E.A.8
Kruyer, W.9
Gotto Jr., A.M.10
-
19
-
-
1842326783
-
Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease
-
Pyörälä K., Pedersen T.R., Kjekshus J., Faergeman O., Olsson A.G., and Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 20 (1997) 614-620
-
(1997)
Diabetes Care
, vol.20
, pp. 614-620
-
-
Pyörälä, K.1
Pedersen, T.R.2
Kjekshus, J.3
Faergeman, O.4
Olsson, A.G.5
Thorgeirsson, G.6
-
20
-
-
0032497945
-
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels. subgroup analyses in the Cholesterol and Recurrent Events (CARE) Trial
-
CARE Investigators
-
Goldberg R.B., Mellies M.J., Sacks F.M., Moyé L.A., Howard B.V., Howard W.J., Davis B.R., Cole T.G., Pfeffer M.A., Braunwald E., and CARE Investigators. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels. subgroup analyses in the Cholesterol and Recurrent Events (CARE) Trial. Circulation 98 (1998) 2513-2519
-
(1998)
Circulation
, vol.98
, pp. 2513-2519
-
-
Goldberg, R.B.1
Mellies, M.J.2
Sacks, F.M.3
Moyé, L.A.4
Howard, B.V.5
Howard, W.J.6
Davis, B.R.7
Cole, T.G.8
Pfeffer, M.A.9
Braunwald, E.10
-
21
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
-
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
-
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 (1998) 1349-1357
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
-
22
-
-
4344683381
-
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS). multi-center randomized placebo-controlled trial
-
CARDS investigators
-
Colhoun H.M., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A., Livingstone S.J., Thomason M.J., Mavkness M.I., Charlton-Menys V., Fuller J.H., and CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS). multi-center randomized placebo-controlled trial. Lancet 364 (2005) 685-696
-
(2005)
Lancet
, vol.364
, pp. 685-696
-
-
Colhoun, H.M.1
Betteridge, D.J.2
Durrington, P.N.3
Hitman, G.A.4
Neil, H.A.5
Livingstone, S.J.6
Thomason, M.J.7
Mavkness, M.I.8
Charlton-Menys, V.9
Fuller, J.H.10
-
23
-
-
0022206133
-
Lipids, diabetes, and coronary heart disease. insights from the Framingham Study
-
Kannel W.B. Lipids, diabetes, and coronary heart disease. insights from the Framingham Study. Am Heart J 110 (1985) 1100-1106
-
(1985)
Am Heart J
, vol.110
, pp. 1100-1106
-
-
Kannel, W.B.1
-
24
-
-
0037049366
-
Diabetes, plasma insulin and cardiovascular disease. subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT)
-
Rubins H.B., Robins S.J., Collins D., Nelson D.B., Elam M.B., and Schaefer E.J. Diabetes, plasma insulin and cardiovascular disease. subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch Intern Med 162 (2002) 2597-2604
-
(2002)
Arch Intern Med
, vol.162
, pp. 2597-2604
-
-
Rubins, H.B.1
Robins, S.J.2
Collins, D.3
Nelson, D.B.4
Elam, M.B.5
Schaefer, E.J.6
-
25
-
-
0026710526
-
Coronary heart disease in NIDDM patients in the Helsinki Heart Study
-
Koskinen P., Manttari M., Manninen V., Huttunen J.K., Heinonen O.P., and Frick M.H. Coronary heart disease in NIDDM patients in the Helsinki Heart Study. Diabetes Care 15 (1992) 820-825
-
(1992)
Diabetes Care
, vol.15
, pp. 820-825
-
-
Koskinen, P.1
Manttari, M.2
Manninen, V.3
Huttunen, J.K.4
Heinonen, O.P.5
Frick, M.H.6
-
26
-
-
0035941990
-
Effect of fenofibrate on progression of coronary artery disease in type 2 diabetes. the Diabetes Atherosclerosis Intervention Study, a randomised study
-
[published correction appears in Lancet 2001;357:1890]
-
Effect of fenofibrate on progression of coronary artery disease in type 2 diabetes. the Diabetes Atherosclerosis Intervention Study, a randomised study. [published correction appears in Lancet 2001;357:1890]. Lancet 357 (2001) 905-910
-
(2001)
Lancet
, vol.357
, pp. 905-910
-
-
-
27
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
Coordinating Committee of the National Cholesterol Education Program
-
Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., Pasternak R.C., Smith Jr. S.C., Stone N.J., and Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
-
(2004)
Circulation
, vol.110
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Merz, C.N.3
Brewer Jr., H.B.4
Clark, L.T.5
Hunninghake, D.B.6
Pasternak, R.C.7
Smith Jr., S.C.8
Stone, N.J.9
-
28
-
-
0029121993
-
Niacin for lipid disorders. indications, effectiveness, and safety
-
192, 193
-
Brown W.V. Niacin for lipid disorders. indications, effectiveness, and safety. Postgrad Med 98 (1995) 185-189 192, 193
-
(1995)
Postgrad Med
, vol.98
, pp. 185-189
-
-
Brown, W.V.1
-
29
-
-
0036369914
-
The treatment of hypertension in adult patients with diabetes
-
Arauz-Pacheco C., Parrott M.A., and Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care 25 (2002) 134-147
-
(2002)
Diabetes Care
, vol.25
, pp. 134-147
-
-
Arauz-Pacheco, C.1
Parrott, M.A.2
Raskin, P.3
-
30
-
-
1042302784
-
Hypertension management in adults with diabetes
-
American Diabetes Association. [position statement]
-
American Diabetes Association. Hypertension management in adults with diabetes. [position statement]. Diabetes Care 27 suppl 1 (2004) S65-S67
-
(2004)
Diabetes Care
, vol.27
, Issue.SUPPL. 1
-
-
-
31
-
-
0038460302
-
The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. the JNC 7 report
-
National High Blood Pressure Education Program Coordinating Committee. [published correction appears in JAMA 2003;290:197]
-
Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., Jones D.W., Materson B.J., Oparil S., Wright Jr. J.T., Roccella E.J., and National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. the JNC 7 report. [published correction appears in JAMA 2003;290:197]. JAMA 289 (2003) 2560-2571
-
(2003)
JAMA
, vol.289
, pp. 2560-2571
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo Jr., J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright Jr., J.T.10
Roccella, E.J.11
-
32
-
-
0032511601
-
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39
-
UK Prospective Diabetes Study Group
-
UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39. BMJ 317 (1998) 713-720
-
(1998)
BMJ
, vol.317
, pp. 713-720
-
-
-
33
-
-
10544229794
-
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
-
Systolic Hypertension in the Elderly Program Cooperative Research Group
-
Curb J.D., Pressel S.L., Cutler J.A., Savage P.J., Applegate W.B., Black H., Camel G., Davis B.R., Frost P.H., Gonzalez N., et al., Systolic Hypertension in the Elderly Program Cooperative Research Group. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 276 (1996) 1886-1892
-
(1996)
JAMA
, vol.276
, pp. 1886-1892
-
-
Curb, J.D.1
Pressel, S.L.2
Cutler, J.A.3
Savage, P.J.4
Applegate, W.B.5
Black, H.6
Camel, G.7
Davis, B.R.8
Frost, P.H.9
Gonzalez, N.10
-
34
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
RENAAL Study Investigators
-
Brenner B.M., Cooper M.E., de Zeeuw D., Keane W.F., Mitch W.E., Parving H.H., Remuzzi G., Snapinn S.M., Zhang Z., Shahinfar S., and RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345 (2001) 861-869
-
(2001)
N Engl J Med
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
de Zeeuw, D.3
Keane, W.F.4
Mitch, W.E.5
Parving, H.H.6
Remuzzi, G.7
Snapinn, S.M.8
Zhang, Z.9
Shahinfar, S.10
-
35
-
-
0036022891
-
The role of angiotensin II antagonism in type 2 diabetes mellitus. a review of renoprotection studies
-
Zanella M.T., and Ribeiro A.B. The role of angiotensin II antagonism in type 2 diabetes mellitus. a review of renoprotection studies. Clin Ther 24 (2002) 1019-1034
-
(2002)
Clin Ther
, vol.24
, pp. 1019-1034
-
-
Zanella, M.T.1
Ribeiro, A.B.2
-
36
-
-
0036464234
-
Current recommendations for the treatment of hypertension. are they still valid?
-
Moser M. Current recommendations for the treatment of hypertension. are they still valid?. J Hypertens 20 suppl 1 (2002) S3-S10
-
(2002)
J Hypertens
, vol.20
, Issue.SUPPL. 1
-
-
Moser, M.1
-
37
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension. principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
HOT Study Group
-
Hansson L., Zanchetti A., Carruthers S.G., Dahlof B., Elmfeldt D., Julius S., Menard J., Rahn K.H., Wedel H., Westerling S., and HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension. principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351 (1998) 1755-1762
-
(1998)
Lancet
, vol.351
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
Dahlof, B.4
Elmfeldt, D.5
Julius, S.6
Menard, J.7
Rahn, K.H.8
Wedel, H.9
Westerling, S.10
-
38
-
-
0033522149
-
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
-
Systolic Hypertension in Europe Trial Investigators
-
Tuomilehto J., Rastenyte D., Birkenhager W.H., Thijs L., Antikainen R., Bulpitt C.J., Fletcher A.E., Forette F., Goldhaber A., Palatini P., et al., Systolic Hypertension in Europe Trial Investigators. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 340 (1999) 677-684
-
(1999)
N Engl J Med
, vol.340
, pp. 677-684
-
-
Tuomilehto, J.1
Rastenyte, D.2
Birkenhager, W.H.3
Thijs, L.4
Antikainen, R.5
Bulpitt, C.J.6
Fletcher, A.E.7
Forette, F.8
Goldhaber, A.9
Palatini, P.10
-
39
-
-
0344373794
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. [published corrections appear in JAMA 2003;289:178 and 2004;291:2196]
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). [published corrections appear in JAMA 2003;289:178 and 2004;291:2196]. JAMA 288 (2002) 2981-2997
-
(2002)
JAMA
, vol.288
, pp. 2981-2997
-
-
-
40
-
-
0007410805
-
Effect of amlodipine on morbidity and mortality in severe chronic heart failure
-
Prospective Randomized Amlodipine Survival Evaluation Study Group
-
Packer M., O'Connor C.M., Ghali J.K., Pressler N.L., Carson P.E., Belkin R.N., Miller A.B., Neuberg G.W., Frid D., Wertheimer J.H., et al., Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 335 (1996) 1107-1114
-
(1996)
N Engl J Med
, vol.335
, pp. 1107-1114
-
-
Packer, M.1
O'Connor, C.M.2
Ghali, J.K.3
Pressler, N.L.4
Carson, P.E.5
Belkin, R.N.6
Miller, A.B.7
Neuberg, G.W.8
Frid, D.9
Wertheimer, J.H.10
-
41
-
-
7244257384
-
Clinical outcomes in the diabetes cohort of the International Verapamil SR-Trandolapril Study (INVEST)
-
INVEST Investigators
-
Bakris G.L., Gaxida E., Messerli F.H., Mancia G., Erdine S., Cooper-DeHoff R., Pepino C.H., and INVEST Investigators. Clinical outcomes in the diabetes cohort of the International Verapamil SR-Trandolapril Study (INVEST). Hypertension 44 (2004) 637-642
-
(2004)
Hypertension
, vol.44
, pp. 637-642
-
-
Bakris, G.L.1
Gaxida, E.2
Messerli, F.H.3
Mancia, G.4
Erdine, S.5
Cooper-DeHoff, R.6
Pepino, C.H.7
-
42
-
-
0036310610
-
UKPDS 60. risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine
-
UK Prospective Diabetes Study Group
-
Kothari V., Stevens R.J., Adler A.I., Stratton I.M., Manley S.E., Neil H.A., Holman R.R., and UK Prospective Diabetes Study Group. UKPDS 60. risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33 (2002) 1776-1781
-
(2002)
Stroke
, vol.33
, pp. 1776-1781
-
-
Kothari, V.1
Stevens, R.J.2
Adler, A.I.3
Stratton, I.M.4
Manley, S.E.5
Neil, H.A.6
Holman, R.R.7
-
43
-
-
0036584224
-
UKPDS 59. hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes
-
UK Prospective Diabetes Study Group
-
Adler A.I., Stevens R.J., Neil A., Stratton I.M., Boulton A.J.M., Holman R.R., and UK Prospective Diabetes Study Group. UKPDS 59. hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25 (2002) 894-899
-
(2002)
Diabetes Care
, vol.25
, pp. 894-899
-
-
Adler, A.I.1
Stevens, R.J.2
Neil, A.3
Stratton, I.M.4
Boulton, A.J.M.5
Holman, R.R.6
-
44
-
-
0027966932
-
Obesity, fat distribution and weight gain as risk factors for clinical diabetes in men
-
Chan J., Rimm E., Colditz G., Stampfer M., and Willett W. Obesity, fat distribution and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17 (1994) 1-10
-
(1994)
Diabetes Care
, vol.17
, pp. 1-10
-
-
Chan, J.1
Rimm, E.2
Colditz, G.3
Stampfer, M.4
Willett, W.5
-
45
-
-
0034959804
-
Cigarette smoking and glycaemia. the EPIC-Norfolk study
-
Sargeant L.A., Khaw K.T., Bingham S., Day N.E., Luben R.N., Oakes S., Welch A., and Wareham N.J. Cigarette smoking and glycaemia. the EPIC-Norfolk study. Int J Epidemiol 30 (2001) 547-554
-
(2001)
Int J Epidemiol
, vol.30
, pp. 547-554
-
-
Sargeant, L.A.1
Khaw, K.T.2
Bingham, S.3
Day, N.E.4
Luben, R.N.5
Oakes, S.6
Welch, A.7
Wareham, N.J.8
-
46
-
-
0036176173
-
Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition
-
Chuahirun T., and Wesson D.E. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis 39 (2002) 376-382
-
(2002)
Am J Kidney Dis
, vol.39
, pp. 376-382
-
-
Chuahirun, T.1
Wesson, D.E.2
-
47
-
-
0034116811
-
Health care and health status and outcomes for patients with type 2 diabetes
-
Harris M.I. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 23 (2000) 754-758
-
(2000)
Diabetes Care
, vol.23
, pp. 754-758
-
-
Harris, M.I.1
-
48
-
-
0033799018
-
Giving smoking cessation the attention that it deserves
-
Glasgow R.E. Giving smoking cessation the attention that it deserves. Diabetes Care 23 (2000) 1453-1454
-
(2000)
Diabetes Care
, vol.23
, pp. 1453-1454
-
-
Glasgow, R.E.1
-
49
-
-
0033803534
-
Intervention study for smoking cessation in diabetic patients. a randomized controlled trial in both clinical and primary care settings
-
Canga N., De Irala J., Vara E., Duaso M.J., Ferrer A., and Martinez-Gonzalez M.A. Intervention study for smoking cessation in diabetic patients. a randomized controlled trial in both clinical and primary care settings. Diabetes Care 23 (2000) 1455-1460
-
(2000)
Diabetes Care
, vol.23
, pp. 1455-1460
-
-
Canga, N.1
De Irala, J.2
Vara, E.3
Duaso, M.J.4
Ferrer, A.5
Martinez-Gonzalez, M.A.6
-
50
-
-
0034725354
-
A clinical practice guideline for treating tobacco use and dependence. a US Public Health Service report
-
The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff and Consortium Representatives
-
The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff and Consortium Representatives. A clinical practice guideline for treating tobacco use and dependence. a US Public Health Service report. JAMA 283 (2000) 3244-3254
-
(2000)
JAMA
, vol.283
, pp. 3244-3254
-
-
-
51
-
-
0003617863
-
-
US Dept of Health and Human Services, Public Health Service, Rockville, MD October
-
Fiore M., Bailey W., Cohen S.J., et al. Treating Tobacco Use and Dependence. Reference Guide for Clinicians (2000), US Dept of Health and Human Services, Public Health Service, Rockville, MD October
-
(2000)
Treating Tobacco Use and Dependence. Reference Guide for Clinicians
-
-
Fiore, M.1
Bailey, W.2
Cohen, S.J.3
-
53
-
-
0030778116
-
The prevention and treatment of obesity. application to type 2 diabetes
-
Maggio C.A., and Pi-Sunyer F.X. The prevention and treatment of obesity. application to type 2 diabetes. Diabetes Care 20 (1997) 1744-1766
-
(1997)
Diabetes Care
, vol.20
, pp. 1744-1766
-
-
Maggio, C.A.1
Pi-Sunyer, F.X.2
-
54
-
-
23944494686
-
Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications
-
Franz M.J., Bantle J.P., Beebe C.A., Brunzell J.D., Chaisson J.L., Garg A., Holzmeister L.A., Hoogwerf B., Mayer-Davis E., Mooradian A.D., et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25 (2002) 148-198
-
(2002)
Diabetes Care
, vol.25
, pp. 148-198
-
-
Franz, M.J.1
Bantle, J.P.2
Beebe, C.A.3
Brunzell, J.D.4
Chaisson, J.L.5
Garg, A.6
Holzmeister, L.A.7
Hoogwerf, B.8
Mayer-Davis, E.9
Mooradian, A.D.10
-
55
-
-
0037715390
-
The management of the obese diabetic patient
-
Albu J., and Raja-Khan N. The management of the obese diabetic patient. Prim Care Clin Office Pract 30 (2003) 465-491
-
(2003)
Prim Care Clin Office Pract
, vol.30
, pp. 465-491
-
-
Albu, J.1
Raja-Khan, N.2
-
56
-
-
0028211087
-
High mono-saturated fat diets for patients with diabetes mellitus. a meta-analysis
-
Garg A. High mono-saturated fat diets for patients with diabetes mellitus. a meta-analysis. JAMA 271 (1994) 1421-1428
-
(1994)
JAMA
, vol.271
, pp. 1421-1428
-
-
Garg, A.1
-
57
-
-
0032933426
-
Effects of the National Cholesterol Education Program's step I and step II dietary intervention programs of cardiovascular risk factors. a meta-analysis
-
Yu-Poh S., Zhao G., Etherton T., Naglak M., Jonnalagadda S., and Kris-Etherton P.M. Effects of the National Cholesterol Education Program's step I and step II dietary intervention programs of cardiovascular risk factors. a meta-analysis. Am J Clin Nutr 69 (1999) 632-646
-
(1999)
Am J Clin Nutr
, vol.69
, pp. 632-646
-
-
Yu-Poh, S.1
Zhao, G.2
Etherton, T.3
Naglak, M.4
Jonnalagadda, S.5
Kris-Etherton, P.M.6
-
58
-
-
0035804277
-
Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet
-
Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., Obarzanek E., Conlin P.R., Miller III E.R., Simons-Morton D.G., et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 344 (2001) 3-10
-
(2001)
N Engl J Med
, vol.344
, pp. 3-10
-
-
Sacks, F.M.1
Svetkey, L.P.2
Vollmer, W.M.3
Appel, L.J.4
Bray, G.A.5
Harsha, D.6
Obarzanek, E.7
Conlin, P.R.8
Miller III, E.R.9
Simons-Morton, D.G.10
-
59
-
-
1842863550
-
The Diabetes Prevention Program (DPP). description of lifestyle intervention
-
The Diabetes Prevention Research Group
-
The Diabetes Prevention Research Group. The Diabetes Prevention Program (DPP). description of lifestyle intervention. Diabetes Care 25 (2002) 2165-2171
-
(2002)
Diabetes Care
, vol.25
, pp. 2165-2171
-
-
-
60
-
-
0031261464
-
Management of obesity in primary care
-
Simkin-Silverman L., and Wing R.R. Management of obesity in primary care. Obes Res 5 (1997) 603-612
-
(1997)
Obes Res
, vol.5
, pp. 603-612
-
-
Simkin-Silverman, L.1
Wing, R.R.2
-
61
-
-
0032693155
-
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina)
-
[published corrections appear in J Am Coll Cardiol 1999;34:314 and 2001;38:296]
-
Gibbons R.J., Chatterjee K., Daley J., Douglas J.S., Fihn S.D., Gardin J.M., Grunwald M.A., Levy D., Lytle B.W., O'Rourke R.A., et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). [published corrections appear in J Am Coll Cardiol 1999;34:314 and 2001;38:296]. J Am Coll Cardiol 33 (1999) 2092-2197
-
(1999)
J Am Coll Cardiol
, vol.33
, pp. 2092-2197
-
-
Gibbons, R.J.1
Chatterjee, K.2
Daley, J.3
Douglas, J.S.4
Fihn, S.D.5
Gardin, J.M.6
Grunwald, M.A.7
Levy, D.8
Lytle, B.W.9
O'Rourke, R.A.10
|